This new report provides analysis of Cannabinoids/Marijuana testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
The report is available by section, and can be customized to specific information needs and budget.
France, Germany, Italy, Japan, Spain, UK, USA
France: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
The report is available by section, and can be customized to specific information needs and budget.
Geographic Coverage
France, Germany, Italy, Japan, Spain, UK, USA
Market Segmentation
Centralized Testing
- Hospitals
- Commercial/Private Laboratories
POC/Decentralized Testing
- Physician Offices/Group Practices
- Emergency Departments
- Ambulatory Care Centers
List of Tables
France: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
